Beta‐blockers for hypertension
87 results
1 - 87
Beta‐blockers for hypertension- Blood pressure lowering efficacy of beta‐1 selective beta blockers for primary hypertension
- Oral beta‐blockers for mild to moderate hypertension during pregnancy
- Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension
- Blood pressure lowering efficacy of beta‐blockers as second‐line therapy for primary hypertension
- Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension: Cochrane systematic review
- Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension: Cochrane systematic review
- First‐line diuretics versus other classes of antihypertensive drugs for hypertension
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
- Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
- First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissection: Cochrane systematic review
- Beta‐blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Cardioselective beta‐blockers for reversible airway disease
- Beta-blockers for preventing stroke recurrence: Cochrane systematic review
- First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension: Cochrane systematic review
- Band ligation versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Beta blockers for peripheral arterial disease: Cochrane systematic review
- Time course for blood pressure lowering of beta‐blockers with partial agonist activity
- Sclerotherapy versus beta‐blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Treatment of hypertension in peripheral arterial disease
- Medical interventions for primary open angle glaucoma and ocular hypertension
- Pharmacological interventions for hypertension in children
- Calcium channel blockers versus other classes of drugs for hypertension
- Beta‐blockers for preventing aortic dissection in Marfan syndrome
- First‐line drugs for hypertension
- Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion‐dependent beta thalassaemia
- Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices
- Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacks: Cochrane systematic review
- Effect of early treatment with anti‐hypertensive drugs on short and long‐term mortality in patients with an acute cardiovascular event
- Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials: Cochrane systematic review
- Carvedilol versus traditional, non‐selective beta‐blockers for adults with cirrhosis and gastroesophageal varices
- Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
- Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension: Cochrane systematic review
- Pharmacotherapy for hypertension in adults aged 18 to 59 years
- Interventions for preventing and managing advanced liver disease in cystic fibrosis
- Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis
- Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
- Platelet count, spleen length, and platelet count‐to‐spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis
- Portosystemic shunts versus endoscopic intervention with or without medical treatment for prevention of rebleeding in people with cirrhosis
- Rho kinase inhibitor for primary open‐angle glaucoma and ocular hypertension
- Interventions for fatigue in people with kidney failure requiring dialysis
- Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews